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sequent training (which cannot occur at 
the shorter spacing intervals). This pro-
posal underscores the importance of the 
generation of discrete waves of MAPK 
activity with each trial.
In summary, the authors have demon-
strated the importance of activation and 
inactivation of MAPK in the first 2 (out 
of 10) training trials leading to long-term 
memory formation in flies. To explore this 
model further, it will now be important to 
test whether a similar on-off switch for 
MAPK activity occurs across trials 3–10 
in normal flies, and in gain-of-function 
corkscrew mutant flies trained using the 
40 min interval protocol. If these predic-
tions are confirmed, this significantly 
advances our understanding of the spac-
ing effect, as it indicates that it is not only 
the activation kinetics of MAPK signaling 
that determine the optimal spacing of 
training sessions, but also the genera-
tion of discrete waves of MAPK that is 
critical. Ultimately, an understanding of 
such activation profiles in patients suf-
fering from disorders of the Ras/MAPK 
signaling pathway such as Noonan’s 
syndrome could, in principle, lead to the 
development of optimal learning strate-
gies that would allow the encoding of 
lasting memories.
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The Mre11-Rad50-Nbs1 (MRN) complex senses DNA double-strand breaks and recruits different 
repair pathway and checkpoint proteins to break foci. Two new studies (Williams et al., 2009; Lloyd 
et al., 2009) identify Nbs1 as a key factor in this process and reveal how an N-terminal protein recruit-
ment module in Nbs1 binds to different response factors through shared phosphopeptide motifs.Of the various types of DNA damage, 
double-strand breaks (DSBs) may be 
the most cytotoxic because of their 
potential to cause gross chromosomal 
aberrations, often linked to cell death 
or cancer. Cells therefore go to great 
lengths to repair DSBs, mounting a 
highly complex multistep response that 
includes modifications to large chroma-
tin domains (“repair foci”) through, e.g., 
ubiquitination, phosphorylation, and 
binding of numerous repair factors, scaf-
folding mediators, and posttranslational 
modifiers (Harper and Elledge, 2007). 
A keystone in the response to DSBs in 
eukaryotic cells is the Nbs1 protein, one 
of the earliest repair factors to bind to 
DSBs. However, Nbs1 also acts later in the repair process to regulate the DNA 
damage checkpoint and to recruit other 
repair factors to DSBs. Two papers in 
this issue of Cell (Williams et al., 2009; 
Lloyd et al., 2009) now provide structural 
and molecular insight into the mecha-
nism by which Nbs1 performs these later 
repair functions.
DSBs are repaired by two major path-
ways, homologous recombination (HR) 
and nonhomologous end joining (NHEJ). 
Homologous recombination uses the 
sister chromatid as a template for new 
DNA synthesis and is highly accurate 
but limited to the S and G2 phases of 
the cell cycle. In NHEJ, in contrast, 
DNA ends are directly ligated without 
the need for sister chromatids, but this Cell 13repair pathway is potentially mutagenic 
and can lead to chromosome aberra-
tions. Repair pathway selection appears 
to be controlled in part by phosphoryla-
tion of repair factors, but the underly-
ing molecular mechanisms are unclear. 
Nbs1, which plays a key role in both DSB 
repair pathways, interacts with different 
response proteins in a phosphorylation-
dependent manner.
Nbs1 is mutated in Nijmegen break-
age syndrome (Carney et al., 1998; 
Varon et al., 1998), which is character-
ized by chromosomal instability, micro-
cephaly, immunodeficiency, and a 
susceptibility to cancer. Nbs1 together 
with the endo/exonuclease Mre11 and 
the ATP binding protein Rad50 form 9, October 2, 2009 ©2009 Elsevier Inc. 25
figure 1. nbs1 and DnA Double-strand Break Repair
The MRN complex (Mre11, blue; Rad50, yellow; Nbs1, green) is a key sensor of DNA double-strand 
breaks (DSBs). DSBs trigger the activation of the DNA damage checkpoint and can be repaired by one of 
two different pathways: homologous recombination or nonhomologous end joining. All of these respons-
es are mediated at some level by Nbs1. (Inset) The FHA domain of Nbs1 binds to a phosphothreonine-
containing motif in Ctp1 and Lif1, proteins involved in homologous recombination and non-homologous 
end joining, respectively. In addition, the BRCT domains of human Nbs1 bind to the same motif when it 
contains phosphoserine, leading to an interaction with the human checkpoint factor Mdc1.the Mre11-Rad50-Nbs1 (MRN) complex 
(Figure 1). Binding of the MRN complex 
to DSBs is one of the first steps in the 
DNA damage response pathway. MRN 
has multiple functions: it tethers DSBs 
via Rad50 coiled-coils, participates in 
the nucleolytic processing of DNA ends, 
and triggers DSB signaling by recruiting 
and activating the kinase ATM (Williams 
et al., 2007). ATM then orchestrates the 
DNA damage response by phosphory-
lating a wide variety of response factors, 
including the tumor suppressor proteins 
Chk2, Brca1, and p53.
However, Nbs1 also acts downstream 
of ATM. Nbs1 interacts with the scaffold-
ing adaptor protein Mdc1 to maintain 
the DNA damage checkpoint and is also 
important in the direct recruitment of 
repair factors to DSBs such as CtIP/Sae2/
Ctp1 and Lif1 (Palmbos et al., 2008). The 
CtIP/Sae2/Ctp1 complex, together with 
MRN, primes DSBs for DNA end resec-26 Cell 139, October 2, 2009 ©2009 Elseviertion during homologous recombination 
(Mimitou and Symington, 2008; Takeda 
et al., 2007), whereas Lif1 is part of the 
DNA ligase IV complex involved in non-
homologous end joining.
The promiscuous downstream role 
of Nbs1 in various DSB signaling and 
repair pathways is not well understood. 
The two new studies by Williams et al. 
(2009) and Lloyd et al. (2009) now com-
bine high-resolution X-ray crystallogra-
phy of the N-terminal phosphoprotein 
interaction module of fission yeast Nbs1 
with genetic and biochemical data on 
yeast and human Nbs1 to reveal Nbs1’s 
molecular adaptor role. The structural 
studies show that a surprisingly tight 
compact module at the N-terminus of 
Nbs1 is formed by a forkhead associated 
(FHA) domain and two Brca1 C terminus 
(BRCT) domains. This protein interaction 
module appears to be connected to the 
C-terminal Mre11 binding motif via a long  Inc.unstructured region, suggesting that the 
N-terminal module recruits response 
factors to DSBs in a spatially flexible way 
that is constrained by distance (Williams 
et al., 2009).
The FHA domain binds to a Ser-Asp-
Thr-Asp-like motif when phosphorylated 
on threonine. These motifs are found in 
fission yeast Ctp1, budding yeast Lif1, 
and as multiple copies in human Mdc1. 
Williams and colleagues reveal further 
details of the phosphopeptide interaction 
in a cocrystal structure of a Ctp1 peptide 
(containing a phosphorylated threonine) 
bound to the FHA domain. They explain 
that the specificity for a phosphorylated 
threonine over a phosphorylated serine 
or tyrosine is due to a tailored binding 
pocket. The conservation of the Ser-
Asp-Thr-Asp motif (or more generally 
Ser-X-Thr motif) in Mdc1, Ctp1 and Lif1 
suggests not only a conserved mode of 
interaction, but also that cells can eas-
ily control molecular events at DSBs via 
casein kinase 2 (CK2). CK2 is a multi-
functional kinase that phosphorylates 
Ser/Thr-Asp motifs and is implicated in 
DNA repair, cell-cycle control, and circa-
dian rhythms.
What about the two BRCT domains? 
Lloyd et al. find that the two BRCT 
domains of human (but not fission yeast) 
Nbs1 also bind to Ser-X-Thr motifs, but 
only when the serine residue is phos-
phorylated. As a consequence, double-
phosphorylated motifs, which occur 
in human Mdc1 for instance, have the 
potential to bind to both FHA and BRCT 
domains. The multiple Ser-X-Thr sites 
may allow for fine-tuning of the interac-
tion between single Mdc1 and Nbs1 mol-
ecules (Lloyd et al., 2009) or crosslinking 
of multiple Nbs1 molecules during forma-
tion of repair foci, but also could interact 
with additional partners. In any case, 
the intriguing role of phosphopeptide-
dependent interaction networks and the 
role of multiple kinases including CK2 
and cyclin-dependent kinases (Huertas 
et al., 2008) suggest a complex mode 
of cell cycle-dependent pathway choice 
and timing of the damage response that 
needs to be addressed in future studies.
The crystal structures also provide a 
molecular framework for understanding 
disease-associated Nbs1 mutations. Sev-
eral missense mutations map to the core 
of BRCT1, presumably perturbing its fold 
or directly interfering with phosphopeptide 
interactions. However, the most frequent 
mutation in patients with Nijmegen break-
age syndrome (?90% of patients) is a five 
base-pair deletion in exon 6 (657 del5), 
which maps to the linker region between 
the two BRCT domains. This mutation 
results in expression of two artificially 
truncated polypeptides, p26 and p70. 
The split occurs between the two BRCT 
repeats and has two consequences. It dis-
rupts the BRCT repeat, likely abolishing its 
direct role in phosphopeptide interactions. 
In addition, the FHA domain in p26 is not 
physically attached to the Mre11 binding 
motif in p70, thus abolishing Nbs1’s ability 
to recruit repair factors to DSBs, which are 
bound by Mre11 and Rad50.
The new work provides a mecha-
nistic look at how Nbs1 recruits repair 
and checkpoint mediators to DSBs and reveals the molecular basis for Nijme-
gen breakage syndrome. Yet there is 
still much to be learned. For instance, 
the role of the BRCT domains needs fur-
ther investigation. What are the ligands 
for the BRCT domains in yeast and what 
is the role of the ATM-dependent phos-
phorylation at serine 278 in this region? 
Likewise, we need to understand how 
the MRN complex activates the ATM 
kinase in the first place. This would take 
us from the “head” of Nbs1 to its “tail.” 
So, one end is just the beginning of the 
next installment of this intriguing story.
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